Opinion: The current conflict in Iran is unlikely to trigger an oil crisis
Svmuu News: Javier Blas, a columnist covering energy and commodities, wrote that while the recent attacks linked to Iran have had a significant impact on oil prices, they have not yet caused a full-scale shock. The article notes that the damage to energy infrastructure and disruptions to tanker routes that the market is concerned about have not yet materialized, and neither Iran nor related parties have taken action against oil infrastructure. The article mentions that even if oil prices rise—with some traders expecting them to climb to $100 per barrel—they would still remain below the highs of $139 during the Russia-Ukraine conflict in 2022 and $147.50 in 2008. At the same time, current long positions are at near-decade highs, and traders are prepared for the risks. (Bloomberg)
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
3
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
4
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
5
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
-
6
Iran-linked exchange Shelbit allegedly sent $676 million to Binance in sanctions-evasion operation, Reuters reports
-
7
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
8
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
9
Analysis: Vanguard Small-Cap Growth ETF (VBK) up 21% YTD 2026, Outperforming Large-Cap Growth ETF (VONG) at 0.3% YTD
-
10
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
Markets Today
Recommended Reading







